651302-82-8

Upstream product

• 651302-71-5 (R)-3-((S)-3-Methyl-4-trimethylsilanylmethyl-pent-4-enoyl)-4-phenyl-oxazolidin-2-one 
• 651302-79-3 ((S)-5-[1,3]Dithian-2-yl-3-methyl-2-methylene-pentyl)-trimethyl-silane 
• 651302-75-9 ((S)-5-Iodo-3-methyl-2-methylene-pentyl)-trimethyl-silane 
• 651303-05-8 (S)-3-Methyl-4-trimethylsilanylmethyl-pent-4-en-1-ol 
• 617714-87-1 ((2S,6R)-6-[2-(4-methoxybenzyloxy)ethyl]-4-methylenetetrahydropyran-2-yl)-acetaldehyde 
• 852991-81-2 2-((S)-4-Bromomethyl-3-methyl-pent-4-enyl)-[1,3]dithiane 

Downstream Products

• 651302-86-2 (2R,5S)-8,8-Dimethoxy-1-{(2S,6R)-6-[2-(4-methoxy-benzyloxy)-ethyl]-4-methylene-tetrahydro-pyran-2-yl}-5-methyl-4-methylene-octan-2-ol 
• 651302-98-6 Acetic acid (2S,4R,6R)-2-[2-(4-methoxy-benzyloxy)-ethyl]-6-{(S)-2-methoxy-3-[(2R,3S,6S)-3-methyl-6-((E)-6-methyl-2-oxo-hept-3-enyl)-tetrahydro-pyran-2-yl]-propyl}-tetrahydro-pyran-4-yl ester 
• 651302-95-3 Acetic acid (5S,6R)-6-((S)-3-{(2R,4R,6S)-4-acetoxy-6-[2-(4-methoxy-benzyloxy)-ethyl]-tetrahydro-pyran-2-yl}-2-methoxy-propyl)-5-methyl-tetrahydro-pyran-2-yl ester 
• 651303-07-0 (2S,4R,6S)-2-((2R,4R,5S)-4-Hydroxy-2,8,8-trimethoxy-5-methyl-octyl)-6-[2-(4-methoxy-benzyloxy)-ethyl]-tetrahydro-pyran-4-ol 
• 651302-89-5 (2R,6S)-2-[2-(4-Methoxy-benzyloxy)-ethyl]-4-methylene-6-((2R,5S)-2,8,8-trimethoxy-5-methyl-4-methylene-octyl)-tetrahydro-pyran 
• 651302-92-0 (2S,6R)-2-[2-(4-Methoxy-benzyloxy)-ethyl]-6-((2S,5S)-2,8,8-trimethoxy-5-methyl-4-oxo-octyl)-tetrahydro-pyran-4-one 

Relevant academic research and scientific papers

Diastereoselectivity in asymmetric allylations: The role of vicinal chirality in the allyl nucleophile for SE2′ reactions with aldehydes

A series of nonracemic homoallylic alcohols have been prepared by asymmetric allylation using the (R,R)-and (S,S)-1,2-diamino-1,2-diphenylethane bis-sulfonamide controller ligands for in situ formation of chiral B-allyl-1,3,2-diazaborolidines. Diastereofa

Leucascandrolide A: A Second Generation Formal Synthesis

(Equation presented) A convergent, second generation formal synthesis of (+)-Leucascandrolide A (1) has been efficiently achieved by providing a flexible, enantiocontrolled strategy toward the bioactive macrolactone component. Advancements for stereocontr